Opioid usage and COVID-19 prognosis: A systematic review and meta-analysisMeta-Analysis Published on 2022-06-012023-07-08 Journal: The American journal of emergency medicine [Category] COVID19(2023년), [키워드] COVID-19 Meta-analysis Mortality opioid severe [DOI] 10.1016/j.ajem.2022.03.048 PMC 바로가기 [Article Type] Meta-Analysis
Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated이집트 환자의 코로나 후 증상 예측자: COVID-19 치료에 사용된 약물은 유죄Article Published on 2022-03-312022-09-11 Journal: PLoS ONE [Category] SARS, 치료기술, [키워드] age Antibiotics Comorbidities Corticosteroid Corticosteroids COVID-19 Critical cross-sectional survey described disease drug Factor fatigue females followed by form Google indicated Infection intake International knowledge Mild mild to moderate Mild to moderate COVID-19 Moderate COVID-19 MOST participant Patient physical predictor presence of comorbidities Prevalence psychological symptom regression analysis severe Sex significantly Symptom Symptoms syndrome the disease these symptoms took place Treatment use of antibiotics was used [DOI] 10.1371/journal.pone.0266175 PMC 바로가기 [Article Type] Article
Delirium severity in critical patients with COVID-19 from an Infectious Disease Intensive Care UnitArticle Published on 2022-02-192023-06-17 Journal: International Journal of Infectious Diseases [Category] MERS, [키워드] COVID-19 delirium neurologic SARS-CoV-2 severe [DOI] 10.1016/j.ijid.2022.02.035 PMC 바로가기 [Article Type] Article
COVID-19 disease severity and associated factors among Ethiopian patients: A study of the millennium COVID-19 care center에티오피아 환자의 Covid-19 질병 심각성 및 관련 요인 : 밀레니엄 Covid-19 Care Center의 연구Research Article Published on 2022-01-272022-09-10 Journal: PLoS ONE [Category] 치료기술, [키워드] 95% CI 95% CIs 95%CI addition adjusted odds ratio age AOR Care center changed Characteristics Chi-square chi-square test conducted country COVID-19 COVID-19 disease COVID-19 disease severity COVID-19 pandemic COVID-19 patient COVID-19 patients cross-sectional cross-sectional study detect develop diabetes Diabetes Mellitus Diagnosis disease disease course disease severity Ethiopian Factor Fever headache Health Health care hypertension identify initial male Mild disease moderate moderate disease multinomial logistic regression objective Older outcome P-value p-values patients problems Randomly reported resource Result risk factor Risk factors selected severe severe COVID-19 severe disease severity Sex Significant significantly Spread statistically significant difference the disease the patient understanding was used were used WHO with COVID-19 with mild disease [DOI] 10.1371/journal.pone.0262896 PMC 바로가기 [Article Type] Research Article
Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccinationCase report Published on 2022-01-012022-10-05 Journal: Clinical Infection in Practice [Category] 변종, [키워드] anti-spike antibody antibody Antibody Response B.1.1.529 B.1.628 breakthrough Breakthrough infection Correlate of protection COVID-19 detectable determine develop E484Q experiments healthy controls immune escape mutation Immunocompromised in viral increased risk mRNA-1273 Multiple Multiple myeloma mutated mutations N440K omicron Patient Prevent Protective response Result S194L SARS-CoV-2 second vaccination severe severe COVID-19 spike Spike protein the SARS-CoV-2 vaccination variant virus [DOI] 10.1016/j.clinpr.2021.100130 [Article Type] Case report
Correlation Between CT Severity Scoring and Diabetes Mellitus in Patients With COVID-19 InfectionInternal Medicine Published on 2021-12-062022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome association calculated Care cause Chest Chest CT chi-square test conducted coronavirus coronavirus disease correlation country COVID-19 COVID-19 patients ctss diabetes Diabetes Mellitus diabetic patient evaluate evaluated group hospital HRCT increased risk Infection lung lung involvement Mild moderate pandemic patients patients with COVID-19 Quantitative Result Retrospective study SARS-CoV-2 Scoring severe Severe COVID-19 Infection severity Spread statistically significant the patient WHO Wuhan, China [DOI] 10.7759/cureus.20199 PMC 바로가기 [Article Type] Internal Medicine
A nomogram predicting severe COVID-19 based on a large study cohort from ChinaMulticenter Study Published on 2021-12-012023-06-19 Journal: The American journal of emergency medicine [Category] MERS, [키워드] COVID-19 nomogram predict Regression severe [DOI] 10.1016/j.ajem.2021.08.018 PMC 바로가기 [Article Type] Multicenter Study
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19초기 IFN-α 시그니처와 지속적인 기능 장애는 심각한 COVID-19에서 NK 세포의 구별되는 특징입니다Multicenter Study Published on 2021-11-092022-09-11 Journal: Immunity [Category] MERS, SARS, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis anti-SARS-CoV-2 Antiviral Cell Clinical course Cohort coronavirus coronavirus disease COVD-19 COVID-19 disease Diseases dysfunction elevated exhibited expression feature fibrosis functional IFN IFN-stimulated gene IFN-stimulated genes IFN-α Immunopathogenesis independent indicate induced genes innate immune system interferon involved ISGs longitudinal Longitudinal analyses lung Lung disease Lung fibrosis moderate Moderate COVID-19 natural killer Necrosis NK cell NK cells outcome Patient performed plasma Plasma levels proteomics respiratory scRNA-seq severe severe acute respiratory syndrome Coronavirus severe COVID-19 Signaling single-cell Single-cell transcriptomics symptom onset TNF TNF response TNF responses transcriptomics Tumor tumor necrosis tumor necrosis factor type 1 IFN. upregulation [DOI] 10.1016/j.immuni.2021.09.002 PMC 바로가기 [Article Type] Multicenter Study
Comparative clinical characteristics among different age group of adult COVID‐19 patients: A multicenter studyOriginal Article Published on 2021-10-282022-10-30 Journal: Immunity, Inflammation and Disease [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 95% confidence interval Abstract Admission age Care Characteristics chronic heart disease clinical Clinical characteristics clinical feature Comparative COVID‐19 COVID‐19 infection COVID‐19 patient COVID‐19 Critical cured death discharged disease Dyspnea FIVE group groups Health higher risk hospital Infectious disease male median age multicenter occurred Odds ratio old age Patient respiratory rate Result severe significantly Symptom Symptoms Treatment [DOI] 10.1002/iid3.550 PMC 바로가기 [Article Type] Original Article
Low blood zinc concentrations in patients with poor clinical outcome during SARS-CoV-2 infection: is there a need to supplement with zinc COVID-19 patients?SARS-CoV-2 감염 동안 임상 결과가 좋지 않은 환자의 낮은 혈중 아연 농도: 아연 COVID-19 환자를 보충할 필요가 있습니까?Article Published on 2021-10-012022-09-11 Journal: Journal of microbiology, immunology, and infection [Category] SARS, 치료제, [키워드] Azithromycin Blood Chloroquine clinical Clinical outcome Concentration COVID-19 median Patient patients with COVID-19 SARS-CoV-2 severe severe COVID-19 significantly lower Zinc zinc supplementation [DOI] 10.1016/j.jmii.2021.01.012 PMC 바로가기 [Article Type] Article